CRH and major depressive disorder: Together, these unbiased, large-scale studies point out that CRH is one of very few genes that can serve as a molecular signature of MDD, which is notorious for its clinical heterogeneity, and that reduced function of cortical CRH+ inhibitory interneurons may contribute to the well-characterized GABAergic pathophysiology of the illness (9, 17–24).